Previous close | 17.53 |
Open | 17.66 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 17.66 - 18.01 |
52-week range | 17.66 - 36.55 |
Volume | |
Avg. volume | 31,615 |
Market cap | 162.758M |
Beta (5Y monthly) | 0.75 |
PE ratio (TTM) | 0.02 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $17.53, indicating a +1.1% shift from the previous trading day.
Walgreens is ramping up its clinical trial offerings with Big Pharma players.
Walgreens Boots Alliance Inc. (NASDAQ:WBA) is facing tumultuous times as it grapples with a challenging turnaround, leading to a drastic decline in its stock value, marking its worst performance in over five years. The company’s shares plummeted by 18% in April, nearing a 26-year low, following a downward revision of its outlook. This revision was accompanied by concerns over decreased consumer spending and the revelation of a substantial unpaid tax liability amounting to $2.7 billion, adding to